ZuraPrep without IPA

OTHER2 trials

Sponsors

Zurex Pharma, Inc.

Conditions

Surgical Site Infection

Phase 1

Safety Study to Evaluate the Contact Sensitizing Potential of Topically Applied ZuraPrep™ and ZuraPrep™ Without IPA

CompletedNCT02160587

Zurex Pharma, Inc.Surgical Site Infection

Start: 2014-07-31End: 2014-10-31Updated: 2015-03-17

Safety Study to Evaluate the Cumulative Irritation Potential of Topically Applied ZuraPrep™ and ZuraPrep™ Without IPA

CompletedNCT02160574

Zurex Pharma, Inc.Surgical Site Infection

Start: 2014-06-30End: 2014-09-30Updated: 2014-10-27